PT-141 (Bremelanotide) — 10mg Research Vial
Bremelanotide
$30.00
PT-141 (Bremelanotide) is a melanocortin receptor agonist studied for its roles in CNS-mediated signaling pathways in preclinical models. Widely studied as a research compound in melanocortin system research. Supplied as a lyophilized powder in a 3mL multi-dose vial. For research use only. Not for human consumption.
Out of stock
Currently unavailable — pending Certificate of Analysis (COA). This compound will be available for order once third-party lab verification is complete.
| Molecular weight | 1,025 Da |
|---|---|
| Sequence origin | Cyclic heptapeptide derived from alpha-MSH |
| Primary pathways | MC1R, MC3R, MC4R, MC5R (melanocortin system) |
| Solubility | Sterile water or bacteriostatic water |
| Storage (lyophilized) | -20°C, protect from light |
| Storage (in solution) | 4°C; use within 14 days of reconstitution |
| Preclinical research areas | Melanocortin receptor binding assays, CNS signaling pathway models, autonomic nervous system studies |
For research use only. Not for human or veterinary use. Certificate of analysis available upon request.